Prostate cancer, biological therapy, signal transduction inhibitors and anti-angiogenesis agents
McKinnon, C.
Idrugs the Investigational Drugs Journal 2(7): 624-628
1999
ISSN/ISBN: 1369-7056 PMID: 16127625 Document Number: 509819
New systemic approaches to the treatment of prostate cancer, biological therapy (including vaccines and antibodies), signal transduction inhibitors and anti-angiogenesis agents were the focus of these ASCO sessions.
Document emailed within 1 workday
Related Documents
Tachibana, K.; Ohtake, T.; Saji, S. 2016: III. Novel Endocrine Therapy with Signal Transduction Inhibitors for Hormone Dependent Breast Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 43(13): 2509-2512Dredge, K.; Dalgleish, A.G.; Marriott, J.B. 2003: Angiogenesis inhibitors in cancer therapy Current Opinion in Investigational Drugs 4(6): 667-674
Leo, O.; Foo, M.; Henkart, P.A.; Perez, P.; Shinohara, N.; Segal, D.M.; Bluestone, J.A. 1987: Role of accessory molecules in signal transduction of cytolytic T lymphocyte by anti-T cell receptor and anti-Ly-6.2C monoclonal antibodies Journal of Immunology 139(11): 3556-3563
Jones, R.E.; Defeo-Jones, D.; McAvoy, E.M.; Vuocolo, G.A.; Wegrzyn, R.J.; Haskell, K.M.; Oliff, A. 1991: Mammalian cell lines engineered to identify inhibitors of specific signal transduction pathways Oncogene 6(5): 745-751
Guse, A.H.; Tsygankov AYu; Bröker, B.M.; Roth, E.; Emmrich, F. 1993: Signal transduction in T lymphocytes and monocytes: effects of the anti-CD4 antibody MAX.16H5 Year in Immunology 7: 175-181
Chelariu-Raicu, A.; Coleman, R.L.; Sood, A.K. 2019: Anti-Angiogenesis Therapy in Ovarian Cancer: which Patient is it Most Likely to Benefit? Oncology 33(7)
Wang, Z-hui.; Liao, Y-hua.; Yuan, J.; Zhang, L.; Wang, M.; Zhang, J-hui.; Liu, Z-ping.; Dong, J-hua. 2007: A therapeutic anti-CD4 monoclonal antibody inhibits T cell receptor signal transduction in mouse autoimmune cardiomyopathy Chinese Medical Journal 120(15): 1319-1325
Ghosh, S.; Narla, R.K.; Zheng, Y.; Liu, X.P.; Jun, X.; Mao, C.; Sudbeck, E.A.; Uckun, F.M. 1999: Structure-based design of potent inhibitors of EGF-receptor tyrosine kinase as anti-cancer agents Anti-Cancer Drug Design 14(5): 403-410
Hirai, F. 2015: III. Role of Anti-Angiogenesis Therapy for Advanced Non-Small Cell Lung Cancer - Current Status and Future Challenges Gan to Kagaku Ryoho. Cancer and ChemoTherapy 42(8): 940-943
Yang, H.; Shen, F.; Weber, G. 1999: Amplified increase in signal transduction activity in cancer cells Anticancer Research 19(6b): 4983-4988
Bunn, P.A.; Chan, D.; Dienhart, D.G.; Tolley, R.; Tagawa, M.; Jewett, P.B. 1992: Neuropeptide signal transduction in lung cancer: clinical implications of bradykinin sensitivity and overall heterogeneity Cancer Research 52(1): 24-31
Klener, P.; Klener, P. 2012: Molecularly-targeted and biological anti-cancer therapy Folia Biologica 58(1): 1-6
Zeitz, M. 1991: Molecular mechanisms of signal transduction. Significance of signal transmission for immune regulation in the intestines with special reference to various differentiation stages of T-lymphocytes Zeitschrift für Gastroenterologie. Verhandlungsband 26: 310
Williams, L.; Mazucco, R. 2002: American Association for Cancer Research - 93rd Annual Meeting. Signal transduction. 6-10 April 2002, San Francisco, CA, USA IDrugs: the investigational drugs journal 5(5): 412-415
Venook, A.P.; Venook, A.P. 2015: The value and effectiveness of angiogenesis inhibitors for colorectal cancer Clinical Advances in Hematology and Oncology: H&o 13(9): 561-563
Caceres, G.; Dauphinee, M.J.; Eisele, L.E.; MacColl, R.; Mizejewski, G.J. 2002: Anti-prostate cancer and anti-breast cancer activities of two peptides derived from alpha-fetoprotein Anticancer Research 22(5): 2817-2820
Xian, J.-M.; Zhou, G.-Y.; Liang, C.-Y.; Liu, S.-X. 2007: Study on interference therapy induced by epidermal growth factor receptor-antisense cDNA in signal transduction of laryngeal squamous cell carcinoma Hua Xi Kou Qiang Yi Xue Za Zhi 25(6): 540
Lu, D-Dong. 2005: Growth factor NUN increased AKR1C2 expression by activated CDK2 related RB signal transduction pathway in human liver cancer cell line Hepato-Gastroenterology 52(62): 567-570
Li, W.W.; Li, V.W.; Brainerd, N.; Fagen, S.J. 2002: Global development of angiogenesis inhibitors for cancer: principles, progress and new paradigms Gan to Kagaku Ryoho. Cancer and ChemoTherapy 29(Suppl 1): 50-58
Christofferson, R. 1998: Angiogenesis inhibitors in advanced cancer. many current clinical trials show promising results Lakartidningen 95(20): 2349-2354